Hyperhomocysteinemia: a renal and cardiovascular risk factor?

被引：0
作者：
Carmine Zoccali
Kitty J. Jager
机构：
[1] Nephrology,Department of Medical Informatics
[2] Hypertension & Renal Transplantation Unit and CNR-IBIM Clinical Epidemiology of Renal Diseases and Hypertension,undefined
[3] Ospedali Riuniti,undefined
[4] ERA-EDTA Registry,undefined
[5] Academic Medical Center,undefined
来源：
Nature Reviews Nephrology | 2010年 / 6卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
One recent trial failed to show any beneficial effect of homocysteine lowering using vitamin B therapy on survival and cardiovascular events in patients with end-stage renal disease, and results of another study in patients with early-stage diabetic nephropathy actually suggested that vitamin B therapy has harmful effects. Do these findings mark the end of the era of studies investigating homocysteine lowering in patients with chronic kidney disease?
引用
收藏
页码：695 / 696
页数：1
相关论文
共 14 条
  • [1] McCully KS(2005)Hyperhomocysteinemia and arteriosclerosis: historical perspectives Clin. Chem. Lab. Med. 43 980-986
  • [2] Heinz J(2010)B vitamins and the risk of total mortality and cardiovascular disease in end-stage renal disease: results of a randomized controlled trial Circulation 121 1432-1438
  • [3] House AA(2010)Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial JAMA 303 1603-1609
  • [4] Kluijtmans LA(1999)The molecular basis of cystathionine beta-synthase deficiency in Dutch patients with homocystinuria: effect of CBS genotype on biochemical and clinical phenotype and on response to treatment Am. J. Hum. Genet. 65 59-67
  • [5] Wald DS(2002)Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis BMJ 325 1202-1117
  • [6] Law M(2006)Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence BMJ 333 1114-1116
  • [7] Morris JK(2006)Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial J. Am. Coll. Cardiol. 47 1108-1588
  • [8] Wald DS(2006)Homocysteine lowering and cardiovascular events after acute myocardial infarction N. Engl. J. Med. 354 1578-1789
  • [9] Wald NJ(2009)Cardiovascular and non-cardiovascular mortality among patients initiating dialysis JAMA 302 1782-undefined
  • [10] Morris JK(undefined)undefined undefined undefined undefined-undefined
12